Lv1
70 积分 2024-07-08 加入
Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses
14天前
已关闭
TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial
2个月前
已完结
Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study
2个月前
已完结
Early response evaluation and CEA response in patients treated in a Danish randomized study comparing trifluridine/tipiracil (TAS-102) with or without bevazicumab in patients with chemorefractory metastatic colorectal cancer (mCRC)
2个月前
已关闭
Novel combination therapy, TAS-102 combined with the anti-EGFR antibody or the anti-VEGF antibody showed therapeutic benefit toward colorectal cancer xenografts
2个月前
已完结
Comparison of the efficacy of third-line treatments for metastatic colorectal cancer: A network meta-analysis
2个月前
已关闭
Myosteatosis and prognosis in cancer: Systematic review and meta-analysis
2个月前
已完结
Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis
2个月前
已完结
Colorectal Postoperative Infective Complications Worsen Oncological Outcomes: A Meta-Analysis
3个月前
已完结
皖公网安备34019202002308
